167 related articles for article (PubMed ID: 2126946)
1. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
Crawford P; Chadwick DJ; Martin C; Tjia J; Back DJ; Orme M
Br J Clin Pharmacol; 1990 Dec; 30(6):892-6. PubMed ID: 2126946
[TBL] [Abstract][Full Text] [Related]
2. The lack of interaction between temafloxacin and combined oral contraceptive steroids.
Back DJ; Tjia J; Martin C; Millar E; Mant T; Morrison P; Orme M
Contraception; 1991 Apr; 43(4):317-23. PubMed ID: 1906791
[TBL] [Abstract][Full Text] [Related]
3. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
Rosenfeld WE; Doose DR; Walker SA; Nayak RK
Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
[TBL] [Abstract][Full Text] [Related]
4. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids.
Crawford P; Chadwick D; Cleland P; Tjia J; Cowie A; Back DJ; Orme ML
Contraception; 1986 Jan; 33(1):23-9. PubMed ID: 3082590
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking.
Kanarkowski R; Tornatore KM; D'Ambrosio R; Gardner MJ; Jusko WJ
Clin Pharmacol Ther; 1988 Jan; 43(1):23-31. PubMed ID: 3121231
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the effect of tenidap sodium on the pharmacokinetics of a combined oral contraceptive.
Coates PE; Mesure R
Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):47S-50S. PubMed ID: 7547095
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation.
Kuhnz W; al-Yacoub G; Fuhrmeister A
Contraception; 1992 Nov; 46(5):455-69. PubMed ID: 1458892
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral contraceptive steroids in Egyptian women: studies with Ovral, Nordette and Norminest.
el-Raghy I; Back DJ; Makeram M; Salem H; Osman F; Fathalla M; Orme ML
Contraception; 1986 Apr; 33(4):379-84. PubMed ID: 3089683
[TBL] [Abstract][Full Text] [Related]
10. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
Rogers SM; Back DJ; Stevenson PJ; Grimmer SF; Orme ML
Br J Clin Pharmacol; 1987 Jun; 23(6):721-5. PubMed ID: 3111513
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC
Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of cyproterone acetate and ethinylestradiol in 15 women who received a combination oral contraceptive during three treatment cycles.
Kuhnz W; Staks T; Jütting G
Contraception; 1993 Dec; 48(6):557-75. PubMed ID: 8131397
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
Jung-Hoffmann C; Fitzner M; Kuhl H
Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of oral contraceptive steroids following the administration of the antimalarial drugs primaquine and chloroquine.
Back DJ; Breckenridge AM; Grimmer SF; Orme ML; Purba HS
Contraception; 1984 Sep; 30(3):289-95. PubMed ID: 6439467
[TBL] [Abstract][Full Text] [Related]
15. The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
Back DJ; Killick SR; Stevenson PJ; Shenoy N; Elstein M; Cohen M
Contraception; 1987 Sep; 36(3):321-6. PubMed ID: 3119288
[TBL] [Abstract][Full Text] [Related]
16. The effect of olestra on systemic levels of oral contraceptives.
Miller KW; Williams DS; Carter SB; Jones MB; Mishell DR
Clin Pharmacol Ther; 1990 Jul; 48(1):34-40. PubMed ID: 2196143
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers.
Cawello W; Rosenkranz B; Schmid B; Wierich W
Epilepsia; 2013 Mar; 54(3):530-6. PubMed ID: 23360419
[TBL] [Abstract][Full Text] [Related]
18. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
19. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
Woutersz TB; Korba VD
Int J Fertil; 1988; 33(6):406-10. PubMed ID: 2906915
[TBL] [Abstract][Full Text] [Related]
20. Possible interaction between oxcarbazepine and an oral contraceptive.
Klosterskov Jensen P; Saano V; Haring P; Svenstrup B; Menge GP
Epilepsia; 1992; 33(6):1149-52. PubMed ID: 1464278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
